Fluidigm Corporation today announced the availability of Single-Cell ATAC-seq, an epigenetics application for the C1TM system, that allows researchers to explore the regulatory systems that drive cellular function. This application is freely available to researchers on Script Hub™, a new web portal within Fluidigm’s C1 Open AppTM program.
In a blood sample taken from a cancer patient, there may be a single circulating tumor cell among hundreds of thousands of other cells. These tumor cells can provide valuable information about how cancer progresses, and could help doctors decide how to treat individual patients, but they are extremely difficult to find.
Scientists in an EU-supported project have developed a microfluidic chip that simultaneously analyses the reactions of several human organ tissues when they come into contact with candidates for new drugs. The ground-breaking device could save millions of euros in drug development costs.
Like the carbon dioxide in a fizzing glass of soda, most bubbles of gas in a liquid don't last long. But nanobubbles persist. These bubbles are thousands of times smaller than the tip of a pencil lead -- so small they are invisible even under most optical microscopes -- and their stability makes them useful in a variety of applications, from targeted drug delivery to water treatment procedures.
We live in fear of 'superbugs': infectious bacteria that don't respond to treatment by antibiotics, and can turn a routine hospital stay into a nightmare. A 2015 Health Canada report estimates that superbugs have already cost Canadians $1 billion, and are a "serious and growing issue." Each year two million people in the U.S. contract antibiotic-resistant infections, and at least 23,000 people die as a direct result.
MIT researchers have shown that they can use a microfluidic cell-squeezing device to introduce specific antigens inside the immune system’s B cells, providing a new approach to developing and implementing antigen-presenting cell vaccines.
Researchers have developed a microfluidic chip that can capture rare clusters of circulating tumor cells, which could yield important new insights into how cancer spreads. The work was funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), part of the National Institutes of Health.
Made from state-of-the-art silicon transistors, an ultra-low power sensor enables real-time scanning of the contents of liquids such as perspiration. Compatible with advanced electronics, this technology boasts exceptional accuracy – enough to manufacture mobile sensors that monitor health.
A new technique invented at MIT can measure the relative positions of tiny particles as they flow through a fluidic channel, potentially offering an easy way to monitor the assembly of nanoparticles, or to study how mass is distributed within a cell.
With certain critical treatments, personalised care includes the ability to monitor the concentration of medicines in the patient's body, in order to adjust the treatment. Researchers at EPFL have come up with a quick and portable new device for measuring the amount of medicinal drugs in blood. Doctors and pharma companies have already expressed interest in this research.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.